RetroSense Therapeutics

Ann Arbor biotechnology company developing a sight-restoration therapy

Biotech & Life Sciences

Sector

Biopharmaceutical therapeutics development

Model

01Company Overview

Ann Arbor biotechnology company developing a sight-restoration therapy. It was acquired by Allergan for $60 million in 2016.

02Backed By1 investor

03Similar Companies

RA

RhyGaze AG

Biotech & Life Sciences

→

BS

RT

VB

AM

04Startup DNA

6

signals

Sectors
Business Model
Technology